Executive Summary Act III of COVID: Navigating the Crosscurrents of Post-Inflation 2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
healthcare growth
Analysis: Seeking Balance in the Hyperactive Mental Health Tech Market
The prevalence of mental and behavioral health conditions has been on the rise in recent decades, further aggravated by the pandemic in the last two years. Social isolation, grief from the loss of loved ones, fear of contracting the virus, and financial worries were all major stress factors that increasingly affected the mental wellbeing of the population, and the resulting statistics are startling: the average share of adults with symptoms of anxiety or depressive disorders jumped from 1
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020. M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Analysis: July Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring. The Nasdaq hit an all-time high during the month of July, sailing through the 10,000 mark to post YTD gains of nearly 20%, representing a 56% increase off the low water mark on March 23. More notably, the Nasdaq has outperformed
Read More
HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know
Healthcare Growth Partners, an
Investment Banking and Strategic Advisory firm exclusively focused on the
transformational health
IT market, today announced the release of its Semi-Annual Health IT Market
Review report that summarizes M&A and private equity activity across health
IT, health information services, and digital health. Report Background/Methodology This edition of the report includes feedback from our survey
of private equity professionals and their response to
Read More
Report: State of Health IT Private Equity in the Era of COVID-19
In May, as the U.S. cautiously started to reopen amid intense controversy, HGP polled hundreds of private equity funds across all stages of investment to find out how COVID-19 has impacted deal flow. Eighty respondents provided their perspective on topics ranging from an appetite for new investments to access to debt to the impact on portfolio companies. Respondent Demographics Effect of COVID-19 on Valuations When asked how they expect overall and Health IT valuations to behave in
Read More
COVID-19 Pandemic: The Surprise Catalyst for Telemedicine Adoption
It is no secret that technology adoption in healthcare often lags adoption in other sectors. Often, the slow pace of adoption makes sense. While technology can drastically improve both cost and quality in healthcare when implemented correctly, it can also cause physician burnout, increased administrative workload, and worsen patient outcomes if a new technology fails to live up to the hype. Historically, the slow pace of IT adoption in healthcare was nowhere more apparent than in the
Read More
COVID-19 Outbreak: The Opportunity & Importance of Health Informatics
Never before has health informatics played a greater role in public health than during the COVID-19 pandemic. While the Health IT industry is certainly challenged due to the overall disruption to the healthcare system, the pandemic undoubtedly underscores the opportunity and importance of health informatics, such as telehealth, remote patient monitoring, patient engagement, AI-based drug discovery, precision medicine, and clinical decision support, but nowhere more pressing than the fields of
Read More
symplr Acquires Quality & Risk Management Platform The Patient Safety Company
- symplr, a leading healthcare governance, risk and compliance (“GRC”) software-as-a-service (“SaaS”) platform has acquired Patient Safety Company, a quality and risk management platform for healthcare organizations. - The strategic acquisition further strengthens industry-leading healthcare governance, risk, and compliance software offerings. symplr, a
leading healthcare governance, risk and compliance (“GRC”)
software-as-a-service (“SaaS”) platform, backed by Clearlake Capital
Read More
